Cost-effectiveness Evaluation of Two 10% Urea Creams in Patients With Diabetic Foot Syndrome

Universidad Complutense de Madrid20 enrolled

Overview

Randomised, double-blind, cost-effectiveness clinical trial of two 10% urea creams purchased in pharmacies and supermarkets in patients with diabetic foot syndrome.

The aim of this study was to evaluate the cost-effectiveness of two 10% urea creams in patients with Diabetic Foot Syndrome. The methodology was a prospective, longitudinal, single-centre, randomised, double-blind, longitudinal clinical trial that evaluated the skin quality of 20 participating feet belonging to 10 patients with Diabetic Foot Syndrome after the application of two 10% urea creams purchased in pharmacies and supermarkets.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

Conditions

Diabetic Foot

Interventions

Participants were given the 10% urea cream purchased in pharmacy or supermarket as appropriate after randomisation and their foot skin quality was assessed by validated questionnaire.OTHER

Participants agreed to the interventions after allocation to each arm according to randomisation and after signing an informed consent form. The creams tested in this study provided to participants are authorised for sale within the European Union but are not considered drugs or medical devices. The main purpose of the interventions was based on the care and assessment of the quality of the skin of the participants' feet.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients \>18 years with Diabetic Foot Syndrome * Deep or superficial sensory neurological involvement diagnosed by Semmes-Weinstein Monofilament and Rydel-Seiffer tuning fork * ABI (Ankle Brachial Index) in normal range * Metabolic Syndrome * No cognitive impairment * Patients who agreed to be included in the study by signing a written consent Exclusion Criteria: * Patients with hypersensitivity or allergy to any of the components of both creams.

Locations (1)

José Luis Lázaro Martínez

Madrid, Spain

Outcomes

Primary Outcomes

Cost analysis of two 10% urea creams purchased in pharmacies and supermarkets.

The cost analysis will be carried out considering the price per ml of 10% urea cream used by the participants during their participation in the study.

Time frame: 5 months

Assessment of the skin quality of participants' feet before and after the cream application intervention using a validated questionnaire.

The assessment of skin quality was carried out using the "Questionnaire for assessment of injury risk and skin quality in patients with diabetic foot syndrome", validated intra-observer and inter-observer by this research group. The minimum score assigned in this questionnaire is 0 points and the maximum score is 12, with higher scores correlating with higher risk of injury and poorer skin quality of the feet.

Time frame: 5 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.